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Classifications of Emphysema 
APNs can play an important role in the 
management of emphysema. It is crucial for 
APNs to understand the pathophysiology of the 
disease and the significance it plays in 
individuals to better diagnose, treat, and 
manage patients. Educating individuals about 
disease and staying up to date on treatment 
options will benefit both the APN and patient. 
COPD: Emphysema
Nicole Nuxol, RN BSN
Introduction Signs & Symptoms References
Berg, K., & Wright, J. L. (2016). The pathology of 
chronic obstructive pulmonary disease. 
Archives of Pathology & Laboratory Medicine, 
140(12), 1423-1428.
Boka, K. (2016, August 31). Emphysema. Retrieved 
June 28, 2017, from 
http://emedicine.medscape.com/article/29828
3-overview#a5
Burt, L., & Corbridge, S. (2013). COPD exacerbations: 
evidence-based guidelines for identification, 
assessment, and management. American 
Journal of Nursing, 113(2), 34-3. 
https://doi.org/10.1097/01.NAJ.0000426688.96
330.60
Dolan, P. L. (2014). Preventing and treating COPD. 
Medical Economics, 91(5), 54-58.
Izaguirre Anariba, D. E. (2017, February 10). Alpha1-
antitrypsin deficiency. Retrieved June 23, 2017, 
from 
http://emedicine.medscape.com/article/29568
6-overview#a5
King Han, M., Dransfield, M., & Martinez, F. (2017, 
March 20). Chronic obstructive pulmonary 
disease: definition, clinical manifestations, 
diagnosis, and staging. Retrieved June 23, 2017, 
from 
http://www.uptodate.com/contents/chronic-
obstructive-pulmonary-disease-definition-
clinical-manifestations-diagnosis-and-
staging?source=search_result&search=emphys
ema&selectedTitle=1~150#H263049416
Mayo Clinic Staff. (2017, April 28). Emphysema. 
Retrieved June 26, 2017, from 
http://www.mayoclinic.org/diseases-
conditions/emphysema/symptoms-causes/dxc-
20317007
Madell, R. (2013, March 26). Emphysema stages. 
Retrieved June 20, 2017, from 
http://www.healthline.com/health-
slideshow/emphysema-stages#2
Mosenifar, Z. (2017, March 02). Chronic obstructive 
pulmonary disease (COPD). Retrieved May 30, 
2017, from 
http://emedicine.medscape.com/article/29766
4-overview#a3
Rennard, S. I., & Drummond, M. B. (2015). Early 
chronic obstructive pulmonary disease: 
definition, assessment, and prevention. Lancet 
(London, England), 385(9979), 1778–1788. 
https://doi.org/10.1016/S0140-6736(15)60647-
X
Sharafkhaneh, A., Hanania, N. A., & Kim, V. (2008). 
Pathogenesis of emphysema: from the bench 
to the bedside. Proceedings of the American 
Thoracic Society, 5(4), 475–477. 
https://doi.org/10.1513/pats.200708-126ET
Spencer, P., & Hanania, N. A. (2013). Optimizing 
safety of COPD treatments: role of the nurse 
practitioner. Journal of Multidisciplinary 
Healthcare, 6, 53–63. 
https://doi.org/10.2147/JMDH.S35711
The Cleveland Clinic Foundation. (2017, May 26).           
Emphysema symptoms & treatment | COPD. 
Retrieved June 28, 2017, from 
https://my.clevelandclinic.org/health/articles/e
mphysema
Conclusion
The main sign of 
Emphysema is dyspnea 
(shortness of breath). 
Many people who have 
emphysema may 
experience fatigue, 
increased mucous 
production, and wheezing 
in the early stages. By the 
time these symptoms 
appear, often much of the 
lung tissue has already 
been destroyed. These 
symptoms can often be 
misdiagnosed for other 
diseases or illnesses 
(Cleveland Clinic 
Foundation, 2017). The 
disease usually progresses 
where individuals will 
experience increasing 
shortness of breath that 
affects their daily activities, 
and eventually individuals 
will experience shortness 
of breath even at rest 
(Mayo Clinic Staff, 2017). 
Other symptoms include:
• Shortness of breath, 
especially during light 
exercise or climbing 
steps
• Ongoing feeling of not 
being able to get 
enough air
• Long-term cough or 
“smoker’s cough” 
• Wheezing
• Long-term mucus 
production
• Ongoing fatigue
• Chest tightness
.
• Education: The biggest risk factor is 
smoking. Smoking cessation is the only 
intervention shown to reduce the rate of 
the disease progression and related to 
mortality (Dolan, 2014). Providing patient 
education about smoking cessation is 
crucial to in advancing the stages of 
emphysema and causing further damage. 
Also, it is important to educate patients 
about proper nutrition, exercise, correct 
ways to use inhalers, and signs and 
symptoms of exacerbations (Rennard & 
Drummon, 2015). 
• Providing annual influenza vaccinations to 
prevent exacerbation (Spencer & Hanania, 
2013).
• Patient diagnosing and monitoring: 
Understanding many patients with 
emphysema are older adults who have 
many co-morbidities that can complicate 
the management and treatment of 
emphysema (Spencer & Hanania, 2013).
• Prescribing appropriate medications for 
patients with emphysema: Long-acting 
bronchodilators are the recommended 
therapy for patients with moderate to 
severe COPD (Spencer & Hanania, 2013). 
Corticosteroids are also another drug 
therapy added to patients with moderate 
to severe COPD. It is important to educate 
the patients on side effects from their 
medications they are prescribed (Spencer 
& Hanania, 2013).
• Evaluating treatment and how adherence 
to treatment: Making sure patients are 
following their treatment plan and have 
appropriate knowledge of disease is 
crucial. Patients may be discouraged about 
disease, it is important for APN to provide 
patients with realistic expectations of 
treatment outcome and provide support to 
patients and family members (Spencer & 
Hanania, 2013). 
Working in the Critical Care Unit at 
Grant Medical Center, many of our 
patients admitted to the unit have a 
history of Chronic Obstructive 
Pulmonary Disease (COPD), and the 
disease can complicate their course of 
treatment. Working with this patient 
population, it is common for these 
patients to experience prolonged time 
on the ventilator and increased length 
of stay. Many patients have multiple 
admissions throughout the year with 
COPD exacerbation, thus decreasing 
lung function and increasing risk for 
mortality.
Chronic Obstructive Pulmonary Disease 
is the third leading cause of death in 
the United States and is affecting more 
than 32 million Americans (Mosenifar, 
2017). The prevalence of the disease 
continues to rise and many people are 
unaware they even have the disease. 
Prevention is essential in decreasing 
the incidence of the disease and 
Advanced Practice Nurses (APN) play a 
vital role. Chronic Obstructive 
Pulmonary Disease (COPD) is a lung 
disease characterized by progressive 
airflow limitation resulting from small-
airway disease and parenchymal 
destruction (Burt & Corbridge, 2013). 
The inflammation further weakens and 
destroys the alveoli, thus decreasing 
gas exchange. This collapse of lung 
leads to air trapping and further 
damage to the alveoli and narrowing of 
the airway (Burt & Corbridge, 2013). 
There are two types of COPD, chronic 
bronchitis and emphysema. 
Emphysema is abnormal permanent 
enlargement of air spaces distal to the 
terminal bronchioles, accompanied by 
the destruction of alveolar walls and 
without obvious fibrosis (Boka, 2016). 
Being able to understand the 
pathophysiology of emphysema will 
allow for providers to accurately assess 
patients and diagnosis the disease. 
Educating patients and family 
members about the disease and 
providing preventative education such 
as risk factors to the disease will help 
prevent escalation of disease. 
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Implications for Nursing
There are two types of emphysema, primary and secondary emphysema. 
Primary emphysema has a genetic component. Primary emphysema is an 
autosomal recessive trait of alpha-1-antitrypsin deficiency. Alpha-1 antitrypsin 
is a proteinase inhibitor and is made in the liver. This gene is a mutation in the 
SERPINA1 gene located in the 14th chromosome. This protein helps protect the 
lungs from damage. If not enough is made, then damage can occur and lead to 
emphysema (Izaguirre Anariba, 2017). Secondary emphysema usually caused 
by environmental factors, mainly from cigarette smoke, occupational and air 
pollutants (Boka, 2016). Below discusses the pathophysiology behind 
emphysema.
• Foreign antigens infiltrate the lung epithelial cell barrier (Boka, 2016).
• Inflammatory immune cells respond. These include polymorphonuclear 
cells, eosinophils, macrophages, CD4, CD8 lymphocytes (Sharafkhaneh, 
Hanania, & Kim, 2008).
• The immune cells transport the antigens to the bronchial associated 
lymphatic tissue layer (Boka, 2016).
• Release of neutrophils, chemotactic factors occur (Boka, 2016).
• Proteolytic enzymes are released mainly by macrophages, which destroys 
the lungs epithelial barrier (Boka 2016).
• Proteases and free radicals are released from neutrophils to further 
damage the epithelial basement membrane (Boka 2016).
• T lymphocytes in the sputum are mainly CD8 cells. These cells release 
chemotactic factors to recruit more cells such as cytokines. This leads to 
structural change to the lungs (Boka 2016).
• Oxidative stress (produced form cigarette smoke and released from 
inflammatory cells) and protease (produced by inflammatory, 
macrophage, and epithelial cells) production further increases the 
inflammation (Boka 2016).
• Protease and anti-protease imbalance causes bronchiolar edema and 
breakdown of lungs elastin (Boka 2016).
• Thus, causing elastic fiber damage to the parenchyma, known as 
emphysema (Burt & Corbridge, 2013). 
Pathophysiology 
Understanding the importance of the pathophysiology and how it affects the individual 
will help providers to understand the disease of emphysema. Below is the significance 
of the pathophysiology of emphysema. 
• Inflammation decreases the elastic recoil of the lung tissue and destroys alveolar 
attachments to small airways (Burt & Corbridge, 2013). 
• Reduction in alveoli with septal wall destruction reduces gas exchange and causes 
the lung to collapse during expiration, thus limiting airflow (Berg, Joanne, & 
Wright, 2016).
• Bronchial inflammation increases pulmonary secretions, muscle contraction, loss 
of alveolar supporting structure and airway edema causes airway narrowing or 
obstruction (Burt & Corbridge, 2013)
• When the airway is narrowed or obstructed, expiratory flow is decreased causing 
hyperinflation of lung from small shallow breaths. (Burt & Corbridge, 2013)
• Dyspnea occurs because the lungs are being overworked. (Burt & Corbridge, 2013)
• Individuals will have the appearance of “barrel-chested” due to too much air 
being trapped in the lungs (The Cleveland Clinic Foundation, 2017).
• Further parenchymal destruction impedes gas exchange and leads to hypoxia. 
(Burt & Corbridge, 2013)
Significance of Pathophysiology 
There are three classifications for emphysema. They are classified 
based off the region of injury. The three types include; centriacinar, 
panacinar, and paraseptal (King Han, Dransfield, & Martinez, 2017).
1. Centriacinar emphysema is mainly localized in the upper lung 
zone and is the most common type of emphysema (Boka, 
2016). This emphysema is specific to the proximal respiratory 
bronchioles with focal destruction (Boka, 2016). Long term 
cigarette smoking and dust inhalation are the most common 
causes of this type
2. Panacinar emphysema is mainly located in the lower half of the 
lungs. This type of emphysema is usually present in individuals 
who are alpha1-antitrypsin deficient (King Han, Dransfield, & 
Martinez, 2017). In this type of emphysema, the entire alveolus 
is destroyed (Boka, 2016).
3. Paraseptal emphysema is mainly in the distal airway structures, 
alveolar ducts, and alveolar sacs (Boka, 2016). The process of 
destruction occurs near the septae of the lungs or pleura and is 
at risk for spontaneous pneumothorax (Boka 2016). 
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